𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The complex between urokinase plasminogen activator (uPA) and its type-1 inhibitor (PAI-1) denotes poor disease outcome in 576 node-negative breast cancer patients

✍ Scribed by P Manders; L Beex; V Tjan-Heijnen; P Span; N Grebenchtchikow; J Geurts-Moespot; T van Tienhoven; C Sweep

Book ID
118622353
Publisher
Elsevier Science
Year
2004
Tongue
English
Weight
176 KB
Volume
2
Category
Article
ISSN
1359-6349

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Complex of urokinase-type plasminogen ac
Complex of urokinase-type plasminogen activator with its type 1 inhibitor predicts poor outcome in 576 patients with lymph node–negative breast carcinoma
✍ Peggy Manders; Vivianne C. G. Tjan-Heijnen; Paul N. Span; Nicolai Grebenchtchiko πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 128 KB πŸ‘ 1 views

## Background: The ability of a solid tumor to grow and metastasize has a significant dependence on protease systems, such as the plasminogen activation system. the plasminogen activation system includes the urokinase-type plasminogen activator (upa) and plasminogen activator inhibitor type 1 (pai-